Abstract
The term “serum inhibitors of myxoviruses” has been used to designate proteinaceous substances differing from antibody and occurring in animal sera. These substances prevent agglutination of red blood cells by myxoviruses and at least some of them also inhibit reproduction of myxoviruses in susceptible cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alexandrova, G. I.: An analysis of the structure of the populations of inhibitor-sensitive and inhibitor-resistant A2 influenza virus strains. Acta virol. 6, 487–497 (1962).
Ananthanaryan, R., and C. J. K. Paniker: Non-specific inhibitors of influenza viruses in normal sera. Bull. Wld Hlth Org. 22, 409–420 (1960).
Anderson, S. G.: Mucins and mucoids in relation to influenza virus action. Aust. J. exp. Biol. med. Sci. 26, 347–411 (1948).
Bang, F. B., M. Foard, and D. T. Karzon: The determination and significance of substances neutralizing Newcastle Virus in human serum. Johns Hopk. Hosp. Bull. 87, 130–143 (1950).
Bartolomei-Corsi, O., A. M. Casazza, A. di Marco, M. Ghione, and A. Zanella: Biological properties of a horse serum inhibitor against influenza A2 viruses. In VIIIth Int. Congr. Microbiol., Abstracts, Montreal, Quebec, Canada, No. D. 30. 5p. 96(1962).
Bayer, M. E.: The reaction of receptor glycoprotein with influenza virus and neuraminidase. An electron microscopic study. Trans. N.Y. Acad. Sci. 26, Suppl. 1103–1111 (1965).
Belyavin, G.: The mechanism of influenza virus haemagglutination as a model of specific receptor adsorption. J. gen. Microbiol. 32, 15–18 (1963).
Belyavin, G., and A. Cohen: Chromatography of influenza virus haemagglutination inhibitors. Virology 18, 144–145 (1962).
Biddle, F., D. S. Pepper, and G. Belyavin: Properties of horse serum gamma inhibitor. Nature (Lond.) 207, 381–383 (1965).
Biddle, F., and K. F. Shortridge: Immunological cross-reactions of influenza virus inhibitors. Brit. J. exp. Path. 48, 285–293 (1967).
Biddle, F., and J. P. Stevenson: Flocculation of influenza viruses by horse serum inhibitor. Nature (Lond.) 209, 1223–1225 (1966).
Blaškovič, D., N. A. Maximovič, B. Styk, and P. Albrecht: Course of adaptation of the inhibitor-resistant influenza virus A2 to ferrets. Čs. Epidem. 10, 158–165 (1961) [in Slovak].
Borecký, L.: A factor destroying virus receptors in pneumococcal cultures. I. Isolation and properties of the factor. Acta virol. 2, 73–83 (1958).
Borecký, L.: Mechanisms of nonspecific resistance of the organism. Bratislava, Vydavatel’stvo Slovenskej akadémie vied 1967 [in Slovak].
Borecký, L., S. Halperen, and W. W. Ackermann: Comparative study of the interaction of polyoma and other hemagglutinating viruses with an isolated bovine mucoprotein. J. Immunol. 89, 752–758 (1962a).
Borecký, L., D. Kočišková, and L. Hána: An attempt to affect the level of serum inhibitors of myxoviruses in vivo. I. Effect of ethionine administration on the level of inhibitors in guinea-pig sera. Acta virol. 5, 236–244 (1961).
Borecký, L., V. Lackovič, and V. Rathová: Surface properties of the egg and mouse lines of Al influenza virus. J. Immunol. 95, 387 (1965).
Borecký, L., V. Lackovič, and V. Rathová, and E. Mrena: The syndrome of adaptation of influenza viruses to laboratory animals. J. Hyg. Epidem. (Praha) 10, 277–287 (1966).
Borecký, L., and V. Rathová: Investigations of possible cross reactions between preparations of Salmonellae containing Vi antigen and inhibitors or antibodies against myxoviruses. Acta virol. 7, 339–349 (1963b).
Borecký, L., and V. Rathová, and D. Kočišková: An attempt to affect the level of serum inhibitors of myxoviruses in vivo. II. Effect of ethionine administration on virus multiplication. Acta virol. 6, 97–104 (1962 c).
Borecký, L., and V. Rathová, and D. Kočišková, and L. Hána: Effect of d-1 ethionine on some factors of nonspecific resistance to myxoviruses. J. Hyg. Epidem. (Praha) 6, 65–70 (1962b).
Borecký, L., and V. Rathová, and O. Križanová: Nonspecific resistance of the organism and myxovirus inhibitors. (Comparison of some antibacterial and antiviral mechanisms.) Folia microbiol. (Praha) 8, 137–146 (1963 a).
Boretti, G., A. Di Marco, and J. Piera: Preparation and characterization of an influenza virus inhibitor from horse serum. G. Microbiol. 12, 55–70 (1964).
Bowarnick, M., and P. M. de Burgh: Virus haemagglutination. Science 105, 550 (1947).
Brans, L. M., E. Hertzberger, and J. L. Binkhorst: Studies on the elimination of nonspecific inhibitor in sera against influenza viruses with the aid of filtrates of Vibrio Cholerae. Antonie v. Leeuwenhoek 19, 309 (1953).
Briody, B. A.: Antigenic mutants of influenza virus. Fed. Proc. 16, 407–408 (1957).
Briody, B. A., and W. A. Cassel: Adaptation of influenza virus to mice. I. Changes in the growth curve of an A prime strain of influenza virus. J. Immunol. 74, 37–40 (1955b).
Briody, B. A., and W. A. Cassel, and M. A. Medill: Adaptation of influenza virus to mice. III. Development of resistance to beta-inhibitor. J. Immunol. 74, 41–45 (1955 a).
Bürgi, W., and K. Schmid: Preparation and properties of Zn-alfa2-glycoprotein of normal human plasma. J. biol. Chem. 236, 1066–1077 (1961).
Burnet, F. M., and J. D. Stone: The receptor-destroying enzyme of V. Cholerae. Aust. J. exp. Biol. med. Sci. 25, 227–235 (1947).
Burnet, J. M.: The effect of periodate on the virus inhibitory qualities of mucoids in solution. Aust. J. exp. Biol. med. Sci. 27, 218 (1949).
Burnet, J. M., and J. F. McCrea: Inhibitory and inactivating action of normal ferret sera against an influenza virus strain. Aust. J. exp. Biol. med. Sci. 24, 277–282 (1946).
Casazza, A. M., A. di Marco, M. Ghione, and A. Zanella: Biological properties of a horse serum inhibitor against influenza A2 viruses. G. Microbiol. 12, 1–14 (1964).
Choppin, P. W., and W. Stoeckenius: Interactions of ether-disrupted influenza A2 virus with erythrocytes, inhibitors, and antibodies. Virology 22, 482–492 (1964).
Choppin, P. W., and I. Tamm: Two kinds of particles with contrasting properties in influenza A virus strains from the 1957 pandemic. Virology 8, 539–542 (1959).
Choppin, P. W., and W. Stoeckenius: Studies of two kinds of virus particles which comprise influenza A2 virus strains. II. Reactivity with virus inhibitors in normal sera. J. exp. Med. 112, 921–944 (1960a).
Choppin, P. W., and W. Stoeckenius: Studies of two kinds of virus particles which comprise influenza A2 virus strains. I. Characterization of stable homogeneous substrains in reactions with specific antibody, mucorpotein inhibitors and erythrocytes. J. exp. Med. 112, 895–920 (1960b).
Chu, C. M.: The action of normal mouse serum on influenza virus. J. gen. Microbiol. 5, 739–757 (1951).
Cohen, A.: Protection of mice against Asian influenza virus infection by a normal horse serum inhibitor. Lancet 1960b II, 791–794.
Cohen, A., and G. Belyavin: Hemagglutination inhibition of Asian influenza viruses: A new pattern of response. Virology 7, 59–74 (1959).
Cohen, A., and G. Belyavin: The influenza virus hemagglutination inhibitors of normal rabbit serum. I. Separation of the inhibitory components. Virology 13, 58–67 (1961).
Cohen, A., and G. Belyavin, and E. Newland: Analysis of the horse serum inhibitor of A2 influenza virus haemagglutination and infectivity. VIIIth Int. Congr. Microbiol., Montreal, Quebec, Canada, No. D. 30. 4, p. 95 (1962).
Cohen, A., and F. Biddle: The effect of passage in different hosts on the inhibitor sensitivity of an Asian influenza virus strain. Virology 11, 458–473 (1960a).
Cohen, A., and F. Biddle: Haemagglutination inhibition. Interaction of influenza viruses with horse serum inhibitor. Nature (Lond.) 198, 508–509 (1963b).
Cohen, A., and F. Biddle, and S. E. Newland: Analysis of horse serum inhibitors of A2 influenza virus haemagglutination. Brit. J. exp. Path. 46, 497–513 (1965a).
Cohen, A., and J. Dorman: Non-specific inhibitors of A2 influenza virus in human sera. Actavirol. 9, 519–525 (1965b).
Cohen, A., S. E. Newland, and F. Biddle: Inhibition of influenza virus haemagglutination: A difference of behavior in sera from a single species. Virology 20, 518–529 (1963 a).
Davoli, R., and O. Bartolomei-Corsi: Nonspecific inhibition of the haemagglutination by influenza viruses. VI. Haemagglutination-inhibition and neutralization of infectivity of influenza viruses of the type A2 by normal guinea pig serum activated by heat. Sperimentale 109, 32–42 (1959).
Dawson, P. S.: The nature of substances present in normal bovine sera inhibiting the activity of parainfluenza 3 virus. J. comp. Path. 73, 428–436 (1963).
Expert committee on respiratory virus diseases. Wld Hlth Org. techn. Rep. Ser., No 170 (1959).
Fauconnier, B., R. M.Lartitégui et D. Barua: Adaptation artificielle du virus grippal aux inhibiteurs du serum normal. I. Obtention, à partir d’une souche sensible d’une variante insensible par culture du virus en présence de son inhibiteur. Ann. Inst. Pasteur 97, 473–478 (1959).
Fiset, P.: Serological techniques. In: Techniques in experimental virology. London and New York: R. J. C. Harris 1964.
Francis, T., Jr.: Dissociation of hemagglutinating and antibody measuring capacities of influenza virus. J. exp. Med. 85, 1–7 (1947).
Fridman, E. A.: Non-specific neutralization of influenza virus and methods for its removal. Thesis Leningrad 1955 [in Russian].
Füresz, J.: Studies on inhibitors of influenza virus haemagglutination in normal rabbit and ferret sera. Canad. J. Microbiol. 5, 505–511 (1959).
Gamburg, V. P.: Haemagglutination inhibitor and neutralizing factor of A2 influenza virus in sera. Acta virol. 5, 317–324 (1961).
Geft, R. A., and R. Ya. Polyak: Removal of thermostable inhibitors against A2 influenza virus from immune horse sera by rivanol. Acta virol. 7, 91 (1963).
Gibbons, R. A.: The sensitivity of the neuraminosidic linkage in mucosubstances towards acid and towards neuraminidase. Biochem. J. 89, 380–391 (1963).
Ginsberg, H., and R. J. Wedgwood: Properdin and the inactivation of viruses. Ann. N.Y. Acad. Sci. 83, 528–532 (1960).
Ginsberg, H. S., and F. L. Horsfall: A labile component of normal serum which combines with various viruses. Neutralization of infectivity and inhibition of hemagglutination by the component. J. exp. Med. 90, 475–495 (1949).
Gorbunova, A. S., V. M. Stakhanova, A. N. Lozhkina, and V. D. Olli: Comparative efficacy of methods for treatment of sera with carbon dioxide, V. Cholerae filtrate and potassium periodate for eliminating unspecific inhibitors of hemagglutination to influenza A2 virus. Vop. Virus. 4, 750–753 (1959) [in Russian].
Gorev, N. E.: The use of broth culture filtrates of Pseudomonas fluorescens for the destruction of non-specific thermostabile (at 56° C) influenza virus inhibitor in human sera. Acta virol. 2, 171–178 (1958).
Gottschalk, A.: Chemistry of virus receptors. In: The viruses (F. M. Burnet and W. M. Stanley). New York and London 1959.
Gottschalk, A.: The chemistry and biology of sialic acids and related substances. Cambridge 1960.
Hána, L.: Some properties of haemagglutination inhibitor against influenza C virus. Proc. of the IVth Int. Congr. Biochem. Vienna 1958, 7, Sympos. 7, 160–162 (1958).
Hána, L.: Non-specific inhibitors of myxoviruses. Zprávy z epidemiol. a mikrobiol. 5, 40–43 (1963a) [in Slovak].
Hána, L., and B. Styk: Influence of delipidisation on the haemagglutination inhibiting activity of rat serum against influenza typ C viruses. Acta virol. 4, 392–393 (1960b).
Hána, L., and B. Styk: Lipoids as inhibitors of heamagglutination-inhibiting activity against “avid” of A2 influenza. Acta virol. 5, 190–192 (1961).
Hána, L., and B. Styk: An attempt to differentiate beta-inhibitor from cofactor occurring in bovine serum. Acta virol. 6, 77–83 (1962).
Hána, L., and B. Styk, and D. Kočišková: Estimation of the distribution and the character of inhibitors against “avid” A2 influenza virus strains in protein fractions of guinea pig and horse sera obtained by paper electrophoresis. Acta virol. 4, 356–364 (1960a).
Hána, L., and B. Styk, and Š. Schramek: Studies on the size of antibodies, cofactor and nonspecific inhibitors of influenza virus using separation on Sephadex G-200. Science Tools 10, 1–4 (1963 b).
Harboe, A., and R. Reenaas: The course of antibody development to influenza A2 strains. Acta path. microbiol. scand. 46, 266–272 (1959).
Harboe, A., and R. Reenaas, and M. Oppedal: Studies on Francis inhibitor of influenza virus hemagglutination in rabbit serum fractions obtained by electrophoresis on starch-grain. Acta path. microbiol. scand. 44, 92–105 (1958).
Hollós, I.: The effect of modified Francis-inhibitors on reproduction of influenza virus. Acta microbiol. Acad. Sci. hung. 10, 82–83 (1963).
Horváth, S.: Comparison of the experimental results obtained in the course of inactivation of non-specific inhibitors in serum by means of the haemagglutination and virus neutralization tests. Arch. ges. Virusforsch. 11, 295–303 (1961).
Isaacs, A., and A. Bozzo: The use of V. cholerae filtrates in the destruction of non-specific inhibitor in ferret sera. Brit. J. exp. Path. 32, 325–335 (1951).
Isachenko, V. A., G. A. Smirnova, and A. S. Gorbunova: Isolation of an inhibitor-sensitive variant from an inhibitor-resistant influenza A2 culture by gel-filtration with Sephadex. Vop. Virus. 10, 97–98 (1965) [in Russian].
James, S. M., and P. Fiset: Serum inhibitors of Asian strains of influenza virus. Nature (Lond.) 184, Suppl. 21, 1656–1657 (1959).
Jandásek, L.: Study of the interaction between the “transition strains” of influenza virus A2 and the inhibitor contained in the sera of normal guinea pigs. J. Hyg. Epidem. (Praha) 8, 44–48 (1964).
Jandásek, L.: Inhibitoren des Influenzavirus. Arch. exp. Vet. Med. 21, 313–318 (1967).
Jensen, K. E.: “Memorandum”. Communicable Disease Center, Montgomery, Alabama, 1958.
Jandásek, L., and A. Montgomery: New set of type A influenza viruses. J. Amer. med. Ass. 164, 2025–2029 (1957).
Jordan, W. S., and R. O. Ozeasohn: The use of RDE to improve the sensitivity of hemagglutination-inhibition test for the serologic diagnosis of influenza. J. Immunol. 72, 229–235 (1954).
Karzon, D. T.: Non-specific viral inactivating substance (VIS) in human and mammalian sera. J. Immunol. 76, 454–463 (1956).
Karzon, D. T., and R. H. Bussell: Studies of the nonspecific inactivation of Newcastle disease virus by mammalian sera. Ann. N.Y. Acad. Sci. 83, 539–550 (1960).
Kathan, R. H., C. A. Johnson, and R. J. Winzler: On the glycoprotein inhibitor of viral hemagglutination from human erythrocytes. Acta Soc. Med. upsalien. 64, 290 (1959).
Kathan, R. H., and R. J. Winzler: Structure studies on the myxovirus hemagglutination inhibitor of human erythrocytes. J. biol. Chem. 238, 21–25 (1963).
Kathan, R. H., and R. J. Winzler, and C. A. Johnson: Preparation of an inhibitor of viral hemagglutination from human erythrocytes. J. exp. Med. 113, 37–45 (1961).
Klein, M., and A. Deforest: A serum inhibitor in animal and human sera of bovine enteroviruses. II. In vivo activity and role in “natural” resistance to infection. J. Immunol. 92, 822–826 (1964b).
Klein, M., G. Evans, A. Deforest, and B. Kleger: A serum inhibitor in animal and human sera of bovine enteroviruses. I. Properties and in vitro activity. J. Immunol. 95, 816–821 (1964a).
Klein, M., G. Evans, and Y. Zellat: Properties of non-antibody inhibitor in the sera of man and other animals. Fed. Proc. 21, 461 (1962).
Konno, J.: Beta-inhibitor, its biological and physico-chemical properties with particular emphasis on the differences from alfa-inhibitor, immune serum and properdin. Tohoku J. exp. Med. 67, 391–405 (1958).
Kosyakov, P. N., M. S. Berdinskikh, and Z. I. Rovnova: Ability of viruses to overcome the action of inhibitors and antibodies. Vop. Virus. 7, 28–35 (1962b) [in Russian].
Kosyakov, P. N., N. M. Gruzdeva, and M. S. Berdinskikh: The problem of the therapeutic effect of specific antibodies and inhibitors in influenza infection. Vop. Virus. 8, 301–307 (1963) [in Russian].
Kosyakov, P. N., and Z. I. Rovnova: Virus-cell system exposed to specific antibody and inhibitors. VIIIth Int. Congr. for Microbiology, Abstracts, Montreal, Quebec, Canada, No. E 32 B. 12. p. 109 (1962a).
Krasovskaya, I. A.: Changes in some properties of influenza A2 virus after treatment with sodium periodate. Vop. Virus. 9, 434–437 (1964) [in Russian].
Krikszens, A. E.: Some chemical and physical characteristics of purified beta-inhibitor from bovine serum. Proc. Soc. exp. Biol. (N.Y.) 126, 176–181 (1967).
Križanová, O., and J. Leško: Separation of gamma-inhibitor on carboxymethyl cellulose. Acta virol. 7, 179–182 (1964).
Križanová, O., V. Rathová, D. Kočišková, and J. Szántó: The purification and some properties of the beta-inhibitor from bovine serum. Bratisl. lek. Listy 43, 22–29 (1963) [in Slovak].
Križanová, O., and F. Sokol: Purification of bovine serum beta inhibitor by chromatographic methods and its reaction with Al influenza virus. Acta virol. 10, 35–42 (1966).
Križanová-Laučíková, O., J. Szántó, and P. Albrecht: Localization of virus hemagglutination inhibitor in the chorioallantoic membrane. Virology 15, 501–503 (1961a).
Križanová-Laučíková, O., J. Szántó, and D. Kočišková: Purification and some properties of the thermostable inhibitor against avid A2 influenza virus from horse serum. Acta virol. 5, 4–11 (1961b).
Križanová-Laučíková, O., J. Szántó, and D. Kočišková, G. Ruttkay-Nedecký, and F. Sokol: Differences in the properties of two inhibitors avid A2 influenza virus strains from horse serum. Acta virol. 5, 12–18 (1961c).
Laurell, A. B.: Inhibitor capacity of some purified human serum proteins on haemagglutination by influenza virus. Acta path. microbiol. scand. 49, 213–222 (1960).
Levy, A. H., P. S. Norman, and R. R. Wagner: Electrophoresis of serum inhibitors of influenza viruses. Fed. Proc. 18, 580 (1959).
Link, F., D. Blaškovič, and J. Raus: On the therapeutic effect of gamma inhibitor in mice infected with an inhibitor-sensitive unadapted A2 influenza virus. Acta virol. 9, 553 (1965).
Link, F., J. Szántó, and O. Križanová: A quantitative assay of the in vivo protective effect of gamma inhibitor against inhibitor sensitive A2 influenza virus strain. Acta virol. 8, 71–75 (1964).
Lippelt, H., u. W. Wirth: Unspezifische Hemmfaktoren im Meerschwein-Normalserum gegenüber Influenza-Viren. Arch. ges. Virusforsch. 9, 497–509 (1959).
Lobodziňska, M., and O. Križanová: The relationship between hemagglutination and adsorption of influenza viruses on red blood cells of different animal species and their total sialic acid content. Arch. Immunol. Ter. dośw. 13, 631–638 (1965).
Lobodziňska, M., and O. Križanová: Purification and properties of an influenza virus inhibitor isolated from mouse lungs. Acta virol. 10, 28–34 (1966).
Luzyanina, T. Ya., and R. Ya. Polyak: Localization on the termolabile virus-neutralizing factors in the protein fractions of rabbit and guinea pig sera. Yearbook Institute of Experimental Medicine of the Academy of Medical Sciences of the USSR, 1957, p. 330–332. Leningrad 1958 [in Russian].
Luzyanina, T. Ya., and R. Ya. Polyak, and A. A. Smorodintsev: Virus-neutralizing activity of non-specific thermolabile normal serum inhibitors against the myxovirus, adenovirus and enterovirus groups. Yearbook Institute of Experimental Medicine of the Academy of Medical Sciences of the USSR, 1960, p. 422–427. Leningrad 1961 [in Russian].
Luzyanina, T. Ya., A. L. Salminen, and A.A. Smorodintsev: Peculiarities of the interaction of thermostable inhibitors from normal sera with type A2 influenza viruses of the 1957 pandemic Acta virol. 4, 137–145 (1960).
Luzyanina, T. Ya., and A. A. Smorodintsev: Neutralization of mumps virus in chick embryo cell cultures. Acta virol. 9, 160–164 (1965).
McCrea, J. F.: Nonspecific serum inhibition of influenza haemagglutination. Aust. J. exp. Biol. med. Sci. 24, 283–291 (1946).
McCrea, J. F.: Mucins and mucoids in relation to influenza virus action. II. Isolation and characterization of the serum mucoid inhibitor of heated influenza virus. Aust. J. exp. Biol. med. Sci. 26, 355 (1948).
Medill-Brown, M., and B. A. Briody: Mutation and selection pressure during adaptation of influenza virus to mice. Virology 1, 301–312 (1955).
Meyer, H. M., Jr., M. R. Hilleman, M. L. Miesse, I. P. Cramford, and A. S. Bankhead: New antigenic variant in Far East influenza epidemic 1957. Proc. Soc. exp. Biol. (N.Y.) 95, 609–6l6 (1957).
Morawiecki, A., and E. Lisowska: Polymerized orosomucoid an inhibitor of influenza virus hemagglutination. Biochem. biophys. Res. Commun. 18, 606–610 (1965).
More virus inhibitors. (Leading articles.) Lancet 1961 I, 755–756.
Mulder, J., de Novijer, and L. M. Blans: The influence of treating ferret influenza antisera with enzymes of crude filtrate of Vibrio cholerae on the titre of the antibodies. Antonie van Leeuwenhoek 18, 128 (1952).
Nagase, M., and Y. Kabata: Possible destruction of antibody by treating human serum with KIO4. Studies on several inhibitors against influenza viruses. Virus (Jap.) 11, 65 (1961) [in Japan with English summary].
Niculescu, I.: Inhibitors of influenza viruses. Microbiologia, parasitologia, epidemiologia (Rumun.) 10, 103–110 (1965) [in Rumunian].
Odin, L.: Sialic acid in human serum protein and meconium. Acta chem. scand. 9, 862 (1955).
Orsi, N.: Inhibitori naturali dell’infettività virale. Riv. Ist. sieroter. ital. 41, 77–91 (1966) [in Italian].
Orsi, N., R. Calio, A. Stasio, and L. Sinibaldi: On the use of influenza virus strains sensitive to non-specific inhibitors in the hemagglutination-inhibition reaction. Riv. Ist. sieroter. ital. 42, 3–15 (1967).
Petrov, K. Yu.: Effect on influenza virus of unspecific virus neutralizing substances in animal sera. Vop. Virus. 5, 167–172 (1960) [in Russian].
Pichuskov, A. V.: Inhibitors of hemagglutination by parainfluenza virus types 1, 2, 3. Vop. Virus. 10, 74–78 (1965) [in Russian].
Polyak, R. Ya., T. Ya. Luzyanina, and A. A. Smorodintsev: Biochemical investigation of influenza virus neutralizing protein fractions of sera from different animals. Acta virol. 3, 61–70 (1959).
Polyak, R. Ya., and A.A. Smorodintsev: Electrophoretic investigations of thermostable inhibitors of type A2 influenza virus in normal animal sera. Acta virol. 5, 1–3 (1961).
Rathová, V.: The possible role of inhibitor in non-specific defence of the organism. Zprávy z epidemiol. mikrobiol. (Praha) 5, 46–52 (1963) [in Slovak].
Rathová, V.: (1965): Unpublished results.
Rathová, V., L. Borecký, and D. Kočišková: An attempt to influence in vivo the serum levels of myxovirus inhibitors. III. The effect of the administration of some vitamins on inhibitors and some other serum factors in guinea pigs and mice. Bratisl. lek. Listy 43, 31–40 (1963) [in Slovak].
Rathová, V., and D. Kočišková: Antibody response after different modes of administration of the influenza virus group A2 in some laboratory animals and the influence of different methods of removing non-specific inhibitors on the titre of specific antibodies in their sera. Čs. Epidem. 10, 170–175 (1961) [in Slovak].
Rathová, V., and D. Kočišková, J. Szántó, O. Laučíková, and L. Hána: Some properties of the virus-neutralizing factor of normal animal sera. Vop. Virus 4, 717–723 (1959) [in Russian].
Reimold, G.: Über die Wechselwirkung von Seruminhibitoren, Hühnererythrocyten und Influenzaviren. Z. Immun.-Forsch. 118, 121–134 (1959).
Rovnova, Z. I., and P. N. Kosyakov: Inhibitors and antibodies in the course of immunization of animals with viral preparations. Acta virol. 11, 69–77 (1967).
Rykowska, R., and L. Sawicki: The gamma-inhibitor of normal horse serum. II. The protective properties of the serum and its fractions against infection of mice and tissue cultures with the Singapore strains of influenza virus. Med. dosw. Mikrobiol. 15, 47–54 (1963) [in Polish].
Sampaio, A. A. C.: Inhibitors of influenza virus haemagglutination in normal animal sera. Bull. Wld Hlth Org. 6, 467–472 (1952).
Sampaio, A. A. C., and A. Isaacs: The action of trypsin on normal serum inhibitors of influenza virus agglutination. Brit. J. exp. Path. 34, 152–158 (1953).
Sawicki, L., and R. Rykowska: The guinea pig and white rat serum inhibitors as a possible factor of natural resistance of these animals to infection with certain strains of influenza virus. Med. došw. Mikrobiol. 15, 55–64 (1963) [in Polish].
Schmidt, B., K. Grossgebauer u. D. Hartmann: Über die Enzymaktivität äthergespaltener Influenzaviren und ihren Einfluß auf unspezifische Seruminhibitoren. Z. Immun.-Forsch. 120, 238–248 (1960).
Shimizu, N., and N. Ishida: The characteristics of both hemagglutinin inhibitors and growth inhibitory substances of influenza viruses found in animal specimens. Tohoku J. exp. Med. 67, 390 (1958).
Shimojo, H., A. Sugiura, J. Akao, and Ch. Enomoto: Studies of a non-specific hemagglutination inhibitor of influenza A (Asian) 57 virus. Bull. Inst. Publ. Health 7, 219–224 (1958).
Shiratori, T., M. Nagase, H. Kudo, T. Kikawa, and Y. Kabata: Characterization of non-specific hemagglutinin inhibitors detectable in the sera of experimental animals. Virus (Jap.) 11, 162–163 (1961).
Simkin, J. L., E. R. Skinner, and H. S. Seshadri: Studies on an acidic glyco-protein-containing fraction isolated from guinea-pig serum. Biochem. J. 90, 316–330 (1964).
Smith, W., and J. C. N. Westwood: Influenza virus haemagglutination. The mechanism of the Francis phenomenon. Brit. J. exp. Path. 31, 725–738 (1950).
Smith, W., and J. C. N. Westwood, and G. Belyavin: Influenza: A study of four virus strains isolated in 1951. Lancet 1951 II, 1189.
Smith, W., and M. A. Westwood: Factors involved in influenza haemagglutination reactions. Brit. J. exp. Path. 30, 48–61 (1949).
Smorodintsev, A. A.: Factors of natural resistance and specific immunity to viruses. Virology 3, 299–321 (1957).
Smorodintsev, A. A., and T. Ya. Luzyanina: Interaction of the thermolabile fractions of normal sera from various animals and the virulent and avirulent strains of the influenza virus. Yearbook Inst. of exp. Med. of the Acad. Med. Sci. USSR, 1957, p. 326–330, Leningrad 1958 [in Russian].
Smorodintsev, A. A., and O. I. Šiškina: The effect of normal laboratory animal sera on influenza virus. Zh. Mikrobiol. (Mosk.) 22, 16–19 (1951) [in Russian].
Springer, G. F.: Human MN glycoproteins: Dependence of blood-group and anti-influenza virus activities on their molecular size. Biochem. biophys. Res. Commun. 28, 510–513 (1967).
Stone, J. D.: Inhibition of influenza virus hemagglutination by mucoids. II. Differential behaviour of mucoid inhibitors with indicator viruses. Aust. J. exp. Biol. med. Sci. 27, 557 (1949).
Stone, J. D.: Adsorptive and enzymatic behaviour of influenza virus during the O-D change. Brit. J. exp. Path. 32, 367–376 (1951).
Stulberg, C. C., R. Schapira, A. R. Robinson, D. H. Basinski, and H. A. Freund: Inhibition of influenza virus hemagglutination by purified plasma mucoproteins. Proc. Soc. exp. Biol. (N.Y.) 76, 704–706 (1961).
Styk, B.: Non-specific inhibitors in normal rat serum for the influenza C type virus. Fol. biol. (Praha) 1, 207–213 (1955).
Styk, B.: Inhibitors of the influenza virus in human sera after passaging in volunteers. Acta virol. 1, 238–239 (1957).
Styk, B.: Sensibilization by means of potassium periodate of inhibitor-resistant A2 influenza virus strains to non-specific serum inhibitors. Nature (Lond.) 193, 954–955 (1962a).
Styk, B.: Effect of some inhibitor-destroying substances on the non-specific inhibitor of C influenza virus present in normal rat serum. Acta virol. 7, 88–89 (1963).
Styk, B., L. Hána, F. Franěk, F. Sokol, and J. Menšík: Investigations on cofactor and influenza antibodies by density gradient zonal centrifugation. Acta virol. 6, 478 (1962 b).
Sugiura, A., H. Shimojo, and C. Enomoto: Studies of the non-specific hemagglutination inhibitor against influenza A2 virus (gamma-inhibitor). II. Physicochemical properties of the gamma-inhibitor. Jap. J. exp. Med. 31, 159–168 (1961 a).
Sugiura, A., H. Shimojo, and C. Enomoto: Studies of the non-specific hemagglutination inhibitor against influenza A2 virus. III. Destruction of gamma-inhibitor by virus enzyme. Jap. J. exp. Med. 31, 169–177 (1961 b).
Szántó, J., O. Križanová, and F. Link: Interaction of gamma-inhibitor with A2 influenza virus. Acta virol. 6, 524–530 (1962).
Takátsy, G., and K. Barb: On the normal serum inhibitors for the avid Asian strains of influenza virus. Acta virol. 3, (Suppl.) 71–79 (1959).
Topciu, V., P. Diosi, E. Moldovan, O. Nevinglovschi, and G. Bran: Serological survey concerning the presence of influenza hemagglutination inhibitors in normal dog sera. Acta virol. 11, 55–57 (1967).
Topciu, V., E. Moldovan, O. Nevinglovschi, N. Rosiu, and P. Diosi: Serological investigations on influenza inhibitors in domestic and wild animals. Rev. Roum. Infra-microbiol. 3, 271–276 (1966).
Toussaint, A. J., and L. H. Muschel: Neutralization of bacteriophage by normal serum. Nature (Lond.) 183, 1825–1827 (1959).
Tyrrell, D. A. J.: Separation of inhibitors of hemagglutination and specific antibodies for influenza viruses by starch zone electrophoresis. J. Immunol. 72, 494–502 (1954).
Voláková, N., and L. Jandásek: A thermostable inhibitor of newly isolated influenza strains in guinea pig serum. Acta virol. 3, 109–112 (1959).
Voluyskaya, E. N., V. I. Tovarnicky, and A. M. Byelikova: The effect of the properdin system on the influenza virus. J. Hyg. Epidem. (Praha) 2, 404–407 (1958).
Wagner, R. R.: A pantropic strain of influenza virus: Generalized infection and viremia in the intact mouse. Virology 1, 497–515 (1955).
Wenner, H. A., A. Monley, and M. K. Jensen: A study of infections caused by mumps and NDV viruses. II. Some properties of specific and nonspecific serum hemagglutination inhibitor components. J. Immunol. 68, 357–368 (1952).
Werner, G. H., R. Sharma, and L. Gogolski: Hemagglutinin inhibition with ether-treated antigen as a more sensitive method to measure the immunological response to an Asian influenza virus vaccine. Arch. ges. Virusforsch. 10, 7–18 (1960).
Whitehead, P. H.: Viral inhibition by polymerized orosomucoid. Biochem. J. 95, 8P (1965).
Whitehead, P. H., T. H. Flewet, J. R. Foster, and H. G. Sammons: Inhibition of influenza virus haemagglutination by polymerized orosomucoid. Nature (Lond.) 208, No 5013, 915–916 (1965).
Yakhno, M. A.: Influence of inhibitor-destructive treatment on influenza antibody. Vop. Virus. 6, 334–335 (1961) [in Russian].
Zakstelskaya, L. Y., and M. A. Yakhno: The sensitivity of different strains of A2 influenza virus to the action of inhibitors occurring in animal sera. Vop. med. Virus. (Mosk.) 5, 71–73 (1958) [in Russian].
Zhdanov, V. M., V. P. Gamburg, and G. J. Svet-Moldavsky: Antigenicity of the inhibitor of influenza virus strain A (Asie) 57. J. Immunol. 82, 9–12 (1959).
Zhdanov, V. M., L. J. Zakstelskaya, V. E. Jefimova, M. A. Yakhno, and S. L. Khait: Antigenic peculiarities of 1957 influenza viruses and serologic indexes of immunity among the population. J. Amer. med. Ass. 167, 1469–1474 (1958).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1969 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Križanová, O., Rathová, V. (1969). Serum Inhibitors of Myxoviruses. In: Arber, W., et al. Current Topics in Microbiology and Immunology. Current Topics in Microbiology and Immunology, vol 47. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46160-6_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-46160-6_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46162-0
Online ISBN: 978-3-642-46160-6
eBook Packages: Springer Book Archive